|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
|2.||Atopic Dermatitis (Atopic Eczema)
|5.||Asthma (Bronchial Asthma)
|1.||Menné, Torkil: 29 articles (12/2013 - 08/2002)|
|2.||Agner, Tove: 15 articles (08/2013 - 01/2003)|
|3.||Johansen, Jeanne D: 14 articles (10/2014 - 03/2005)|
|4.||Heinrich, Joachim: 14 articles (06/2014 - 10/2002)|
|5.||Menné, T: 14 articles (01/2012 - 06/2000)|
|6.||McLean, W H Irwin: 13 articles (03/2014 - 03/2007)|
|7.||Holland, Steven M: 13 articles (02/2014 - 01/2004)|
|8.||Thyssen, Jacob P: 12 articles (07/2015 - 06/2010)|
|9.||Werfel, T: 12 articles (12/2012 - 01/2001)|
|10.||Ruzicka, T: 11 articles (04/2015 - 03/2002)|
|1.||Adrenal Cortex Hormones (Corticosteroids)IBA
06/01/2015 - "Clinical efficacy of two topical corticosteroids in the management of chronic hand eczema."
01/01/2014 - "However, in both patients the eczema responded well to a short course of topical corticosteroids. "
11/01/2013 - "An 18-year-old atopic Brazilian patient consulted for recurrent facial eczema that improved slightly under topical corticosteroids. "
01/01/2002 - "It is postulated that they will replace topical corticosteroids as first-line treatment of eczema."
01/01/1991 - "Improvement in the eczema was seen in 27/37 (73%) patients, by discharge from hospital their disease severity score had fallen to a median of 27% of the pretreatment figure, and only 3/27 required topical corticosteroids. "
|2.||Tacrolimus (Prograf)FDA LinkGeneric
09/01/2005 - "The percent improvement from baseline in eczema area and severity index scores was also significantly greater in tacrolimus-treated patients (54.8%) compared with vehicle-treated patients (20.8%). "
10/01/2012 - "We assessed the safety and efficacy of sequential therapy with oral tacrolimus and topical tacrolimus in the treatment of generalized AD using the Eczema Area and Severity Index and the Physician Global Assessment scores as the primary end points. "
07/01/2007 - "Both treatments were effective in reducing signs and symptoms of eyelid eczema, with a near superior benefit for tacrolimus in terms of eczema (total skin score) signs (P=0.05). "
06/01/2005 - "the proportion of patients with at least 60% improvement in the modified Eczema Area and Severity Index (mEASI) between baseline and month 3. By month 3, more patients in the 0.1% tacrolimus group responded to treatment (72.6% vs. 52.3% in the corticosteroid group, P < 0.001). "
04/01/2010 - "In terms of eczema treatment, two systematic reviews have confirmed the efficacy of topical tacrolimus ointment. "
|3.||Cyclosporine (Ciclosporin)FDA LinkGeneric
09/01/1996 - "Cyclosporine at 3 mg/kg/day is as effective as topical BDP in the treatment of chronic hand eczema. "
09/01/1996 - "Both cyclosporine and BDP improved the eczema. "
09/01/1996 - "All measures of eczema severity improved during the Neoral treatment period. "
09/01/1996 - "The aim of this study was to compare oral cyclosporine at 3 mg/kg/day with topical 0.05% beta-methasone-17,21-dipropionate (BDP) cream in the treatment of chronic hand eczema. "
09/01/1996 - "In a previous open study cyclosporine showed efficacy in chronic hand eczema. "
|4.||Immunoglobulin E (IgE)IBA
01/01/2012 - "Only parental eczema was significantly associated with positive outcomes for food challenges with milk after correction for age, sex, atopic comorbidity in the child and milk-specific IgE test results (odds ratio 3.1, 95% confidence interval 1.5-6.3). "
07/01/1992 - "Serum IgE returned to normal and their eczema cleared up. "
09/01/2015 - "We examined gut microbiome development in the first year of life in relation to innate immune responses and onset of IgE-associated eczema over the first 2.5 years in predisposed children due to maternal atopy [www.anzctr.org.au, trial ID ACTRN12606000280505]. "
02/01/2011 - "Specific IgE of ten common food items was measured for a group of consecutive AD patients (n=85) enrolled during a randomized trial and correlated the findings with eczema severity. "
01/01/2011 - "A recent infant study demonstrated that pre and postnatal Lactobacillus rhamnosus HN001 (HN001) supplementation decreased the prevalence of eczema and IgE associated eczema. "
|5.||pimecrolimus (Elidel)FDA Link
01/01/2007 - "Pimecrolimus cream 1% is effective in asteatotic eczema: results of a randomized, double-blind, vehicle-controlled study in 40 patients."
01/01/2007 - "Pimecrolimus cream 1% is effective in patients with asteatotic eczema."
01/01/2004 - "In the published studies on the efficacy of the topical immunomodulator pimecrolimus, different eczema scores were used, and the impact on morphological key signs of eczema was not analysed. "
01/01/2007 - "Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema."
01/01/2007 - "Randomised controlled trials of 1.0% topical pimecrolimus used twice daily compared against other topical comparators for treating eczema. "
03/01/2011 - "Blinded, controlled studies have found that oral alitretinoin is well tolerated and effective in the treatment of severe chronic hand eczema (CHE). "
08/01/2014 - "Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy."
10/01/2009 - "Alitretinoin has been shown to be effective in a randomized controlled trial, and is currently the only treatment specifically licensed for the treatment of hand eczema. "
01/01/2010 - "Oral alitretinoin (9-cis-retinoic acid) is a unique panagonist retinoid with immunomodulatory and anti-inflammatory activity that has emerged as a novel treatment for chronic hand eczema. "
09/01/2008 - "[Alitretinoin: a new treatment option for chronic refractory hand eczema]."
01/01/2014 - "We describe a novel treatment of mucocutaneous peristomal junction breakdown in a patient with severe eczema using aerosol steroids, where conventional methods failed to achieve healing. "
05/01/1971 - "Efficacy of two fluorinated topical steroids in the treatment of common eczemas, on a once a day treatment schedule."
01/01/2013 - "Her GP diagnosed a patch of eczema; however, a trial of topical steroids was not effective and she was referred to dermatology. "
10/01/1986 - "A monkey (Macaca fascicularis), diagnosed as having eczematous dermatitis on the basis of histopathology of a skin biopsy, was used to study the percutaneous absorption of 2 anti-inflammatory steroids. "
01/01/2014 - "Observation and photographic evidence showing resolution of severe peristomal eczema in a patient, in whom systemic steroids were contraindicated, using a topical aerosol steroid. "
12/01/2004 - "To study whether oral psoralen-UV-A (PUVA) with a portable tanning unit at home is as effective as hospital-administered bath PUVA in patients with chronic hand eczema. "
10/01/2012 - "Is there still a role for psoralen ultraviolet A in the treatment of chronic hand eczema?"
10/01/2012 - "Is there still a role for psoralen ultraviolet A in the treatment of chronic hand eczema?"
12/01/2004 - "Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy."
07/06/2013 - "The aim of this study was to investigate the effect of iontophoresis combined with local psoralen plus ultraviolet A (PUVA) therapy in chronic foot eczema. "
12/01/2001 - "Hand eczema can have complex causative or aggravating influences, and the pattern, history, and patch test data are helpful in identifying sources and antigen substitution. "
01/01/2000 - "Based on this single small trial, maternal antigen avoidance was associated with a nonsignificant reduction in eczema severity. "
01/01/1996 - "Based on this single small trial, maternal antigen avoidance was associated with a nonsignificant reduction in eczema severity. "
07/01/1967 - "[Experimental studies on the antigen problem of 2,4-dinitrochlorbenzol eczema]."
01/01/2014 - "We undertook to assess the prevalence and severity of pediatric eczema in Natuashish (population 792), and investigate the level of sensitization to common food antigens. "
|10.||mometasone furoate (mometasone)FDA LinkGeneric
05/01/1999 - "It is concluded that long-term, intermittent treatment of chronic hand eczema with mometasone furoate fatty cream is effective and safe."
02/01/2013 - "The Clinical Efficacy of Mometasone Furoate in Multi-Lamellar Emulsion for Eczema: A Double-blinded Crossover Study."
02/01/2013 - "A multi-center randomized, double-blind, controlled study was performed to assess the efficacy and safety of mometasone furoate cream in MLE for Korean patients with eczema. "
05/01/1999 - "We compared the efficacy and safety of two different schedules for the treatment of chronic hand eczema with a potent topical corticosteroid, mometasone furoate. "
05/01/1999 - "Long-term, intermittent treatment of chronic hand eczema with mometasone furoate."
05/01/2013 - "For all infants with eczema, good skin care is the mainstay of treatment but identifying and avoiding triggers (both allergic and non-allergic) is important in some infants. "
01/01/2008 - "Thus, skin care product selection can have an important clinical effect on the clearance of mild to moderate eczema."
10/01/2005 - "Significant improvement of eczema with skin care and food elimination in small children."
05/01/2015 - "This study evaluated the efficacy of 2 steroid-free, nonprescription eczema skin care formulations for reducing the risk of flare and relieving symptoms in infants and children with AD: Body Cream for the daily maintenance treatment of atopic skin and Flare Treatment for the treatment of atopic flares. "
08/01/2013 - "The aim of the present study was to examine the knowledge of skin care and treatment of hand eczema (HE) in a sample of patients with newly reported occupational HE. "
02/01/2000 - "Smoking is likely to be a reason for the failure of bath-PUVA therapy in the treatment of chronic palmoplantar eczema, in particular regarding smokers with eczema of the dyshidrotic type where no complete remission was achieved."
05/01/1997 - "Systemic PUVA therapy may be useful in the treatment of chronic palmoplantar eczema. "
02/01/2000 - "In order to evaluate environmental influences possibly having an impact on the efficacy of this therapy, smokers and non-smokers suffering from palmoplantar eczema treated with bath-PUVA therapy were compared. "
02/01/2000 - "Does smoking influence the efficacy of bath-PUVA therapy in chronic palmoplantar eczema?"
05/01/1997 - "Local bath-PUVA therapy is of value in the management of chronic palmoplantar eczema resistant to standard modes of topical treatment. "
07/01/2015 - "Eczema Area and Severity lndex (EASI) was assessed at baseline and three weeks after treatment. "
10/01/2006 - "Considering the EASI scores before and after treatment and the final effective rate, good therapeutic effects were obtained in both the combination experimental groups and the control groups (P < 0.01), and there were no differences in the global therapeutic effect between the two groups in patients with eczema and with AD (P > 0.05). "
10/01/2005 - "After treatment, 90% had mild, 10% moderate and 0% severe eczema. "
10/01/2005 - "The eczema extent and severity was estimated with SCORAD before and after treatment. "
01/01/2003 - "Ulceration developed in multiple sites after treatment as well as significant symptoms and signs of varicose eczema, which took at least 2 months to heal despite appropriate topical treatments and compression. "
09/11/1993 - "In both patients the taking of the graft was proven by study of blood subgroups and correction of the immunodeficiency, normalization of platelet number and function and disappearance of cutaneous eczema were seen. "
01/01/2013 - "Eczema in full-thickness skin graft."
01/01/1972 - "[Endogenous eczema in a split-thickness skin graft]."
01/01/1954 - "[Eczema of Thiersch's graft following radical surgery]."
02/01/1952 - "Eczema threatening integrity of skin graft."
09/01/2010 - "Thus, optimization of APTs and progress in the knowledge of the pathophysiology of eczemas could help to develop new immunobiological diagnostic methods and specific immunotherapy for AD."
03/01/2010 - "Eczema area and severity index scores in 20 patients with AD decreased significantly after immunotherapy (P < 0.001). "
08/01/2009 - "Thus, optimization of APTs and furtherance of knowledge of the pathophysiology of eczemas could help to develop new immunobiological diagnostic methods and AD-specific immunotherapy."
10/01/2007 - "Specific subcutaneous immunotherapy (SCIT) with house dust mite (HDM) preparation has recently been shown to improve eczema in patients with atopic dermatitis (AD). "
01/01/2003 - "Efficacy of sublingual immunotherapy in asthma and eczema."